Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2017
The Urticaria Activity Score-Validity, Reliability, and ResponsivenessTomasz Hawro, Tatevik Ohanyan, Nicole Schoepke, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2017
Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trialMartin Metz, Andrea Schütz, Karsten Weller, et al.
Experimental Dermatology|September 14, 2016
Membrane-bound stem cell factor is the major but not only driver of fibroblast-induced murine skin mast cell differentiationMandy Leist, Cathleen Annett Sünder, Sebastian Drube, et al.
Experimental Dermatology|August 9, 2017
Mast cells are critical for the limitation of thrombin-induced skin inflammationCathleen A Suender, Mandy Leist, Magnus Åbrink, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2016
Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled studyKaroline Krause, Athanasios Tsianakas, Nicola Wagner, et al.
Frontiers in Immunology|August 29, 2022
Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot studyDorothea Terhorst-Molawi, Katharina Lohse, Katharina Ginter, et al.
Drugs|March 13, 2025
Update on the Treatment of Chronic Spontaneous UrticariaPavel Kolkhir, Jie Shen Fok, Emek Kocatürk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Effective treatment with mepolizumab in a patient with refractory Wells syndromeDorothea Terhorst-Molawi, Sabine Altrichter, Joachim Röwert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 1, 2019
Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to TreatmentPavel Kolkhir, Martin K Church, Sabine Altrichter, et al.
Acta Dermato-Venereologica|March 3, 2026
Catastrophizing in Chronic Itch: Associations with Demographic, Clinical and Psychological FactorsIsabel Niemeyer, Pascale Salameh, Hanna H Linß, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2017
The Urticaria Activity Score-Validity, Reliability, and ResponsivenessTomasz Hawro, Tatevik Ohanyan, Nicole Schoepke, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2017
Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trialMartin Metz, Andrea Schütz, Karsten Weller, et al.
Experimental Dermatology|September 14, 2016
Membrane-bound stem cell factor is the major but not only driver of fibroblast-induced murine skin mast cell differentiationMandy Leist, Cathleen Annett Sünder, Sebastian Drube, et al.
Experimental Dermatology|August 9, 2017
Mast cells are critical for the limitation of thrombin-induced skin inflammationCathleen A Suender, Mandy Leist, Magnus Åbrink, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2016
Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled studyKaroline Krause, Athanasios Tsianakas, Nicola Wagner, et al.
Frontiers in Immunology|August 29, 2022
Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot studyDorothea Terhorst-Molawi, Katharina Lohse, Katharina Ginter, et al.
Drugs|March 13, 2025
Update on the Treatment of Chronic Spontaneous UrticariaPavel Kolkhir, Jie Shen Fok, Emek Kocatürk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Effective treatment with mepolizumab in a patient with refractory Wells syndromeDorothea Terhorst-Molawi, Sabine Altrichter, Joachim Röwert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 1, 2019
Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to TreatmentPavel Kolkhir, Martin K Church, Sabine Altrichter, et al.
Acta Dermato-Venereologica|March 3, 2026
Catastrophizing in Chronic Itch: Associations with Demographic, Clinical and Psychological FactorsIsabel Niemeyer, Pascale Salameh, Hanna H Linß, et al.
Pageof 26